Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed
Abstract Mycobacterium tuberculosis, the cause of Tuberculosis (TB), infects one third of the world’s population and causes substantial mortality worldwide. In its shortest format, treatment of TB requires six months of multidrug therapy with a mixture of broad spectrum and mycobacterial specific an...
Guardado en:
Autores principales: | Matthew F. Wipperman, Daniel W. Fitzgerald, Marc Antoine Jean Juste, Ying Taur, Sivaranjani Namasivayam, Alan Sher, James M. Bean, Vanni Bucci, Michael S. Glickman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f66b6683dbd843a1b6958015744bf3a6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Microbiome and Tuberculosis: Early Evidence for Cross Talk
por: Sivaranjani Namasivayam, et al.
Publicado: (2018) -
Dysbiosis in the Human Microbiome of Cholangiocarcinoma
por: Benchen Rao, et al.
Publicado: (2021) -
Dysbiosis of the microbiome in gastric carcinogenesis
por: Natalia Castaño-Rodríguez, et al.
Publicado: (2017) -
Extreme Dysbiosis of the Microbiome in Critical Illness
por: Daniel McDonald, et al.
Publicado: (2016) -
Microbiome dysbiosis in lung cancer: from composition to therapy
por: Ning-Ning Liu, et al.
Publicado: (2020)